We remain optimistic that Evusheld will retain its efficacy against Omicron variant Akanki Sharma Mar 3, 2022 Dr Anil Kukreja, Vice President, Medical Affairs and Regulatory, AstraZeneca India, tells Akanki Sharma about Evusheld, which was…
AstraZeneca’s Asthma drug Benralizumab gets marketing approval from DCGI EP News Bureau Dec 22, 2020 Benralizumab is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients
AstraZeneca signs MoU with RSSDI to empower one crore Indian Diabetic patients by 2023 EP News Bureau Nov 26, 2020 Chronic kidney diseases is associated with significant patient death and an increased risk of heart failure. Therefore, it is…
